Guillet, R., Stoll, B.J., Cotten, C.M., Gantz, M., McDonald, S., Poole, W.K. and Phelps, D.L. (2006) National Institute of Child Health and Human Development Neonatal Research Network. Association of H2-Blocker Therapy and Higher Incidence of Necrotizing Enterocolitis in Very Low Birth Weight Infants. Pediatrics, 117, 137-142.
https://doi.org/10.1542/peds.2005-1543

has been cited by the following article:

• TITLE: New Frontiers of Necrotizing Enterocolitis: From Pathophysiology to Treatment

  AUTHORS: Umut Zubarioglu, Sinan Uslu, Ali Bulbul

  KEYWORDS: Preterm Infants, Necrosis, Necrotizing Enterocolitis

  JOURNAL NAME: Health, Vol.9 No.1, January 13, 2017

  ABSTRACT: Necrotizing enterocolitis [NEC] is an inflammatory disease of intestine largely occuring in preterm infants with a wide range of damage from minimal injury limited to mucosa to extensive necrosis of bowel wall and perforation. Despite advancements in neonatal care, mortality remains high [30% - 50%] and controversy still persists with regards to the most appropriate management of neonates with necrotizing enterocolitis. The main factors thought to be involved in the pathogenesis of NEC are: relatively hyper-reactive state of premature intestine, enteral feeding and bacterial colonization. In this review, we discuss current knowledge about the epidemiology, pathophysiology, imaging, medical and surgical management of necrotizing enterocolitis and describe novel strategies for prevention and treatment.